- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Bausch & Lomb PureVision contact lenses available
Bausch & Lomb's PureVision contact lenses are available in the United States once again, following the recent successful resolution of a patent dispute.
May 1
- Fort Lauderdale, FL - Bausch & Lomb's PureVision contact lenses are available in the United States once again, following the recent successful resolution of a patent dispute.
The silicone hydrogel lenses can be prescribed for daily wear or continuous wear for up to 30 days and nights, according to Paul G. Howes, president of Bausch & Lomb North America. "The PureVision lens design provides wearers exceptional vision, health, and comfort, whether the lenses are removed each day or worn 30 days straight, including overnight," Howes said.
Ophthalmologists and optometrists across the United States soon will receive the lens sets, containing a range of PureVision lens prescription powers, to help fit their patients. More information is available at www.purevision.com.
